Companies:

 

Articles:

 

Stock summary

Companies:

 

Impedimed Limited (ASX: IPD)

 
Service provided by WebLinkIR

Company news

Cover Image for ImpediMed’s BIS technology gains recognition as NCCN includes in oncology guidelines for lymphoedema assessment

ImpediMed’s BIS technology gains recognition as NCCN includes in oncology guidelines for lymphoedema assessment

Cover Image for AstraZeneca sources ImpediMed’s SOZO devices for upcoming clinical trial

AstraZeneca sources ImpediMed’s SOZO devices for upcoming clinical trial

Cover Image for ImpediMed welcomes NCCN’s updated breast cancer guidelines to provide early lymphoedema screening

ImpediMed welcomes NCCN’s updated breast cancer guidelines to provide early lymphoedema screening

Cover Image for ImpediMed offers first glimpse into PREVENT trial results

ImpediMed offers first glimpse into PREVENT trial results